Surgery for Pancreatic Neuroendocrine Neoplasms (pNENs)

Chapter

Abstract

Are rare (incidence of 1/100,000; represent 1–2 % of all pancreatic neoplasms)

Keywords

Serotonin Bilirubin Glucagon Amylase Erythromycin 

Further Reading

  1. Akerstrom G, Falconi M, Kianmanesh R, Ruszniewski P, Plockinger U. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. Neuroendocrinology. 2009;90(2):203–8.PubMedCrossRefGoogle Scholar
  2. Delle FG, Kwekkeboom DJ, Van CE, Rindi G, Kos-Kudla B, Knigge U, et al. ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95(2):74–87.CrossRefGoogle Scholar
  3. Falconi M, Bartsch DK, Eriksson B, Kloppel G, Lopes JM, O’Connor JM, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 2012;95(2):120–34.PubMedCrossRefGoogle Scholar
  4. Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95(2):98–119.PubMedCrossRefGoogle Scholar
  5. Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 2005;19(5):753–81.PubMedCrossRefGoogle Scholar
  6. Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012;61(1):6–32.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of SurgeryKantonsspital St. GallenSt. GallenSwitzerland

Personalised recommendations